- Did you mean
- estimated
Search results - 9 results
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
current trends. METHODS: This analysis includes a literature review, Delphi process, and mathematical modelling to estimate HCV prevalence (viraemic infection, defined as HCV RNA-positive cases) and the cascade of ...
Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method
Estimates about the number of people living with HCV in Belgium are rare and even less is known about the prevalence of HCV among PWID. Methods: Between February and April 2019, PWID were recruited in ...
Hepatitis C virus prevalence in Belgium
C population estimate Seroprevalence Abstract: Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. ...
Hepatitis C virus prevalence in Belgium
C population estimate Seroprevalence Abstract: Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
to estimate the budgetary impact of reimbursement of direct-acting antivirals (DAA s). In Belgium, the restricted reimbursement criteria are mainly guided by regional seroprevalence estimates of 0.87% ...
Rapport annuel 2016: virus de l'hépatite C (VHC)
diagnostiqués reste stable depuis 2008. Sur la base du nombre de cas enregistrés dans le réseau des laboratoires vigies et du nombre de génotypages effectués, on estime l’incidence annuelle de l’hépatite C à 1500 ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
are scarce, and particularly for people who inject drugs. The current study refines the existing HCV estimates by focussing on diagnostic HCV testing practices for this population at risk. METHODS: The ...
Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method
capture-recapture harm reduction hidden population multiplier method People who inject drugs treatment Abstract: Background For Belgium, available estimates of the number of people who inject drugs (PWID) are based ...
Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.
sexes were found. Modelling identified the individual’s age and province as relevant factors. The probability of HEV seropositivity increases significantly with age. An estimated total of 434 819 (yearly ...